Exploring the causal relationship between telomere regulation, aging and neurological disorders
Ageing Research Reviews · 2026
DOI: 10.1016/j.arr.2025.102930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026. Verfasst von Gaurav Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Centre of Medical and Bio-all…. Hauptthemen laut MEDLINE: Aging, Telomere, Nervous System Diseases, Telomere Homeostasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 308 Literaturangaben.
Abstract (Originalsprache)
Telomere biology is important for aging and is the cause of the pathogenesis of many neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), stroke, and brain tumors. Telomere shortening is considered to play a role in neurodegeneration, immune senescence, and cerebrovascular dysfunction. Shorter leukocyte telomere length (LTL) is associated with increased risk and severity of stroke, poorer cognitive outcomes in AD, and increased neuroinflammation in MS, highlighting a possible biomarker for disease progression. Glioblastoma and medulloblastoma are characterized as adult and childhoodd neoplasms,respectively; however they aree similarinn terms of telomere regulatio,nwhicht allows malignant growth. However, disease pathophysiology has been associated with telomere dynamics, oxidative stress, and neuroinflammation, but the causal association between telomere attrition and neurological disorders is still unclear. In studies of Mendelian randomization, neurodegenerative diseases have been associated with telomere length regulation in addition to telomere attrition. Approaches to target telomeres include telomerase activators for neuroprotection, telomerase inhibitors, and ALT-directed therapies for brain tumors. These telomere-derived biomarkers should be further refined, and their mechanistic links to the acceleration of neurodegeneration should be determined. Telomere-modifying therapies should be balanced to optimize benefits with minimal oncogenic risks. This review explores the causal relationship between telomere biology, aging, and neurological disorders, indicating novel therapeutic strategies and future directions in telomere research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emi…
- Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
- Department of Zoology, Kalindi College, University of Delhi, India; Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali 140413, India. Electronic address: jhasaurabh017@gmail.com.
Zitieren
APA
Gupta, G., Ali, H., Singh, S. K., Dua, K., & Jha, S. K. (2026). Exploring the causal relationship between telomere regulation, aging and neurological disorders. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102930
Vancouver
Gupta G, Ali H, Singh SK, Dua K, Jha SK. Exploring the causal relationship between telomere regulation, aging and neurological disorders. Ageing Research Reviews. 2026. doi:10.1016/j.arr.2025.102930
BibTeX
@article{Gupta2026,
author = {Gupta, Gaurav and Ali, Haider and Singh, Sachin Kumar and Dua, Kamal and Jha, Saurabh Kumar},
title = {Exploring the causal relationship between telomere regulation, aging and neurological disorders},
journal = {Ageing Research Reviews},
year = {2026},
doi = {10.1016/j.arr.2025.102930}
}
EUVIMED